Targeted therapies are a cornerstone of precision treatment, which exploits information about the genes and proteins altered in a person’s cancer. By designing drugs that interfere with specific molecules in cancer cells, our scientists are innovating strategies to thwart these cells’ ability to proliferate, survive, and metastasize while causing minimum harm to normal cells and tissues.
Pictured: Physician-scientist Ping Chi studies critical genetic and epigenetic drivers that cause normal cells to turn into cancer cells, specifically melanoma and sarcoma. Insights from her work offer new possibilities for the development of targeted therapies.
